MEDAGLINI, DONATA
 Distribuzione geografica
Continente #
NA - Nord America 5.921
EU - Europa 5.540
AS - Asia 916
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 4
OC - Oceania 4
AN - Antartide 1
Totale 12.409
Nazione #
US - Stati Uniti d'America 5.894
GB - Regno Unito 1.382
IE - Irlanda 1.193
IT - Italia 808
SE - Svezia 638
CN - Cina 634
UA - Ucraina 509
FR - Francia 293
DE - Germania 286
FI - Finlandia 228
VN - Vietnam 122
SG - Singapore 75
RU - Federazione Russa 54
ES - Italia 30
BE - Belgio 27
IN - India 25
CA - Canada 22
CZ - Repubblica Ceca 17
PL - Polonia 17
TR - Turchia 14
IR - Iran 10
EU - Europa 9
NL - Olanda 9
GR - Grecia 8
HK - Hong Kong 7
CH - Svizzera 6
JP - Giappone 6
DK - Danimarca 5
IQ - Iraq 5
AT - Austria 4
NO - Norvegia 4
AU - Australia 3
BO - Bolivia 3
BR - Brasile 3
EG - Egitto 3
MT - Malta 3
TH - Thailandia 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
EE - Estonia 2
ID - Indonesia 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 12.409
Città #
Southend 1.208
Dublin 1.188
Fairfield 889
Chandler 679
Ashburn 545
Jacksonville 418
Woodbridge 399
Seattle 325
Houston 315
Wilmington 313
Siena 299
Cambridge 296
Ann Arbor 246
Princeton 199
Beijing 165
Nanjing 135
Dong Ket 121
Helsinki 95
New York 82
San Mateo 73
Boardman 64
San Diego 62
Lancaster 56
Lappeenranta 55
Shanghai 53
Florence 50
Shenyang 50
Menlo Park 48
Nanchang 42
Singapore 40
Moscow 37
Rome 36
Dearborn 30
Málaga 27
Brussels 26
Tianjin 26
Hebei 23
Kunming 23
London 23
Washington 23
Jiaxing 22
Fremont 20
Milan 18
San Francisco 18
Norwalk 16
Redwood City 15
Brno 12
Lastra a Signa 12
Jinan 11
Los Angeles 11
Toronto 11
Zhengzhou 10
Agliana 9
Guangzhou 9
Düsseldorf 8
Hangzhou 8
Phoenix 8
Changsha 7
Izmir 7
Montreal 7
Bacoli 6
Falls Church 6
Mestre 6
Ningbo 6
Poggibonsi 6
Redmond 6
Baghdad 5
Baronissi 5
Bolsena 5
Changchun 5
Chicago 5
Hefei 5
Hounslow 5
Kilburn 5
Saint Louis 5
Taizhou 5
Tokyo 5
Venezia 5
Amsterdam 4
Bangalore 4
Barolo 4
Copenhagen 4
Figline Valdarno 4
Gdynia 4
Lanciano 4
Lanzhou 4
Naples 4
New Bedfont 4
Nuremberg 4
Oslo 4
Padova 4
Roccagorga 4
Shaoxing 4
Tappahannock 4
Trevi 4
Triggiano 4
Vienna 4
Andover 3
Atlanta 3
Bologna 3
Totale 9.204
Nome #
Vaginal immunization to elicit primary T-cell activation and dissemination. 227
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 224
Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation 219
A stochastic model for CD4+ T cell proliferation and dissemination network in primary immune response 191
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 189
Modulation of Primary Immune Response by Different Vaccine Adjuvants. 184
Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. 172
Identification of a branching process model for adaptive immune response 164
Role of the microbiota in the modulation of vaccine immune responses 162
Nuovi approci diagnostici nelle infezioni pneumococciche: possibile ruolo della Real-time PCR e dei biomarcatori 162
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 161
Characterization of the antigen-specific CD4+ T cell response induced by prime-boost strategies with CAF01 and CpG adjuvants administered by the intranasal and subcutaneous routes 159
Big science for vaccine development 157
Correlates of vaccine-induced protective immunity against Ebola virus disease 157
Ebola vaccine R&D: Filling the knowledge gaps 157
Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae 155
13C-NMR determination of simultaneous xylose and glucose fermentation by a newly isolated strain (G11) of Klebsiella planticola 152
Transcriptomics of the vaccine immune response: Priming with adjuvant modulates recall innate responses after boosting 152
Optimized protocol for the detection of multifunctional epitope-specific CD4+ T cells combining MHC-II tetramer and intracellular cytokine staining technologies 151
Vaccination in the elderly: The challenge of immune changes with aging 149
Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells 139
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 137
Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine 134
Adoptive transfer of transgenic T cells to study mucosal adjuvants. 131
null 131
O:2-CRM(197) Conjugates against Salmonella Paratyphi A 130
The European research effort for HIV/AIDS, malaria and tuberculosis 129
In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii 129
Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4(+) and CD8(+) T cells in the genital and intestinal tracts. 128
Immunization with the conjugate vaccine Vi-CRM(197) against Salmonella Typhi induces Vi-specific mucosal and systemic immune responses in mice 128
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 128
Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response 126
Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge 126
Vaccine adjuvants: A priority for vaccine research. 124
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 124
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA. 123
Assessment of mucosal immunity to HIV-1 123
Gram-positive commensal bacteria for mucosal vaccine delivery. 121
Innate immunity against HIV: a priority target for HIV prevention research 121
ADITEC: joining forces for next-generation vaccines 121
Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii 120
Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii 118
Biotechnological approaches to fight pathogens at mucosal sites 118
Recombinant Gram-positive bacteria as vehicles of vaccine antigens 118
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice 118
Valutazione della risposta al test IGRA in pazienti pediatrici contatto di TBC o con sospetto clinico di infezione attiva 116
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii 113
Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice 113
Surface display of recombinant proteins on Bacillus subtilis spores 113
Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface 112
Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria 111
Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii 110
Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. 107
Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery. 107
Vaginal immunization with recombinant gram-positive bacteria 107
Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens 106
The European effort towards the development of mucosal vaccines for poverty-related diseases. 103
null 102
Human dendritic cells are superior to B cells at presenting a major histocompatibility complex class II-restricted heterologous antigen expressed on recombinant Streptococcus gordonii 100
Engineering the gram-positive cell surface for construction of bacterial vaccine vectors 99
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities 99
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization 98
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 97
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination 94
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity? 94
Recombinant Streptococcus gordonii as a mucosal vaccine vector 92
In vivo primary activation of CD4+ and CD8+ T-cells following mucosal vaccination 88
CTA1-DD has an Adjuvant Effect Once Expressed on the Surface of the Gram-Positive Bacterium Streptococcus gordonii 87
In vivo mucosal delivery of bioactive human interleukin 1 recepor antagonist produced by Streptococcus gordonii 84
Nasal and vaginal routes of immunization for CD4+ and CD8+ T-cell priming 81
Induzione primaria di linfociti T CD4 nel tessuto linfoide associato al naso (NALT) in seguito ad immunizzazione con Streptococcus gordonii 80
Expression of immunomodulating molecules on the surface of the vaccine vector Streptococcus gordonii 79
Computational Analysis of Multiparametric Flow Cytometric Data to Dissect B Cell Subsets in Vaccine Studies 79
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population 79
NMR Investigation of the Simultaneous Fermentation of Xylose and Glucose by a Selected Strain of Klebsiella Planticola (G11) 78
From bivariate to multivariate analysis of cytometric data: Overview of computational methods and their application in vaccination studies 78
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 77
Antibody response and protection from challenge in mice immunized with recombinant Streptococcus gordonii expressing fragment C of tetanus toxin 77
NMR investigation of the simultaneous fermentation of xylose and glucose by a selected strain of Klebsiella planticola (G11) 76
Comparison of Immune Responses Elicited by BNT162b2, mRNA-1273 and ChAdOx1 COVID-19 Vaccines. 76
CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines 75
Mucosal vaccine delivery in the female genital tract by recombinant Gram-positive bacteria 75
Primary T-cell response to mucosal vaccination 74
Editorial: Advanced Immunization Technologies for Next Generation Vaccines 73
Long-term anti-bacterial immunity against systemic infection by Salmonella enterica serovar typhimurium elicited by a GMMA-based vaccine 73
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses 73
Expression of measles virus antigens in Streptococcus gordonii 72
NMR investigation of the simultaneous fermentation of xylose and glucose by a selected strain of Klebsiella planticola (G11) 71
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 71
Secretion of heterologous proteins in Streptococcus gordonii (Streptococcus sanguis) Challis. 69
Recombinant gram-positive bacteria for intranasal immunization: characterization of the murine nasal-associated lymphoid tissue and study of local T-cell priming 68
Oral priming of mice using recombinant spores of Bacillus subtilis 67
Cross talk among bacteria and dendritic cells 67
Mucosal adjuvants 65
Human dendritic cells present very efficiently a heterologous antigen expressed on the surface of recombinant Gram-positive bacteria to CD4+ T lymphocites 64
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine 63
Primary activation of CD4+ and CD8+ T cells following mucosal vaccination with recombinant bacteria 62
Physicochemical characterization cascade of nanoadjuvant–antigen systems for improving vaccines 62
Impact of interproximal composite restorations on periodontal tissue health: Clinical and cytokine profiles from a pre-post quasi-experimental study 62
Expression of fusion proteins in the naturally transformable Streptococcus gordonii (Streptococcus sanguis) Challis 61
Totale 11.268
Categoria #
all - tutte 44.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.367 294 71 154 372 153 195 196 301 172 239 77 143
2020/20211.990 75 199 50 160 105 192 83 253 236 253 175 209
2021/20221.596 117 226 98 159 64 27 85 53 84 143 184 356
2022/20232.363 147 238 319 306 213 466 61 206 182 49 119 57
2023/20242.030 73 67 160 118 79 518 668 65 43 87 35 117
2024/2025128 128 0 0 0 0 0 0 0 0 0 0 0
Totale 12.626